JN-2528

N/A

Report date: 2023/10/25 09:12:54
NME

Base Information

Drug NameJN-2528
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase inhibitors
TargetsCyclin-dependent kinase
Therapy Area/IndicationsPsoriasisInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJC (Wuxi) Company Inc
China Registration ClassN/A

Develop Information

Active CompaniesJC (Wuxi) Company Inc
Inactive CompaniesN/A
Active IndicationsPsoriasisInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A